Recombinant Human Uroplakin-1a (UPK1A)

What is UPK1A and what are its primary cellular functions?

UPK1A is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. These cell-surface proteins are characterized by four hydrophobic domains and mediate signal transduction events involved in cell development, activation, growth, and motility. UPK1A is found in the asymmetrical unit membrane (AUM) where it forms complexes with other tetraspanin proteins .

Primary functions include:

• Regulation of normal bladder epithelial physiology

• Maintenance of membrane permeability in superficial umbrella cells

• Stabilization of apical membranes through AUM/cytoskeletal interactions

• Possible tumor suppression in several cancer types

How is UPK1A expression distributed across normal tissues?

Although often described as urothelium-specific, UPK1A expression extends beyond the bladder epithelium. Analysis by RT-PCR confirms UPK1A expression in:

Expression patterns suggest UPK1A plays roles beyond bladder function, particularly in reproductive biology .

What detection methods are most reliable for UPK1A analysis in research settings?

Multiple validated methods for UPK1A detection include:

• RT-qPCR: Highly sensitive for mRNA expression analysis with primers targeting conserved regions

• Western Blotting: Effective using polyclonal antibodies raised against synthesized polypeptides of human UPK1A

• Immunohistochemistry (IHC): Successful detection in paraffin-embedded tissues with specific antibodies

• Immunofluorescence: Useful for colocalization studies with other membrane proteins like CD9

• Immunogold EM-labeling: High resolution analysis of subcellular localization

For standardization, positive controls should include normal urothelium samples where UPK1A expression is consistently high .

How does UPK1A expression correlate with cancer progression and prognosis?

UPK1A demonstrates complex, tissue-specific expression patterns in different cancer types:

The seemingly contradictory expression patterns across cancer types suggest tissue-specific functions of UPK1A, potentially as both an oncogene and tumor suppressor depending on cellular context .

What molecular mechanisms underlie UPK1A's tumor suppressive functions?

In gastric cancer and esophageal cancer models, UPK1A appears to function as a tumor suppressor through multiple mechanisms:

• Cell Cycle Regulation: Overexpression of UPK1A in the MKN45 gastric cancer cell line induces G1 phase arrest, inhibiting cell proliferation

• Migration Inhibition: Elevated UPK1A expression significantly reduces cell migration capabilities

• Invasion Suppression: UPK1A overexpression inhibits invasive potential of cancer cells

• Metastasis Control: Evidence suggests UPK1A may inhibit down-regulation of MMP7, a matrix metalloproteinase involved in metastasis

Experimental approach: To study these mechanisms, researchers typically employ gain-of-function studies using UPK1A-overexpressing cell lines and analyze cell cycle distribution via flow cytometry, migration via wound healing assays, and invasion through Matrigel-coated transwell chambers .

What is the relationship between UPK1A and HIF-1α in cancer metabolism?

UPK1A participates in a positive feedback loop with hypoxia-inducible factor 1α (HIF-1α) that modulates cancer cell metabolism and proliferation:

• HIF-1α directly binds to hypoxia response elements (HRE) in the UPK1A promoter region

• This binding upregulates UPK1A expression under hypoxic conditions

• UPK1A in turn regulates HIF-1α activity, affecting downstream glycolysis enzymes

• This feedback loop enhances the Warburg effect (increased glucose metabolism) in cancer cells

Functional studies demonstrate that silencing UPK1A suppresses glycolysis and proliferation in hepatocellular carcinoma cells, indicating its potential role in cancer metabolism reprogramming .

Experimental approach: ChIP assays can confirm HIF-1α binding to the UPK1A promoter, while metabolic assays measuring glucose consumption, lactate production, and expression of glycolytic enzymes can assess the functional impact of this interaction .

What is the significance of UPK1A in reproductive biology?

UPK1A plays unexpected roles in fertilization and reproductive processes:

• Localization: In oocytes, UPK1A colocalizes with CD9 on the cell surface and in multivesicular body-derived exosomes

• Post-translational Modification: The cytoplasmic tail of UPK1A undergoes conserved fertilization-dependent, Fyn-mediated tyrosine phosphorylation

• Exosome Association: UPK1A is present on egg exosomes in the perivitelline space and zona pellucida, partially colocalizing with CD9 and CD81, which are known to play key roles in fertilization

Electron microscopy studies confirm UPK1A association with plasma membrane, microvilli, and intraluminal vesicles of multivesicular bodies in reproductive cells .

How does the long non-coding RNA UPK1A-AS1 influence cancer progression?

UPK1A-AS1, the antisense RNA to UPK1A, demonstrates complex and sometimes contradictory roles in different cancer types:

These findings reveal that UPK1A-AS1 may function as either an oncogene or tumor suppressor depending on the cellular context .

Research methodology: RNA-seq and RT-qPCR for expression analysis; luciferase reporter and RNA pull-down assays to verify RNA-RNA interactions; functional assays (proliferation, migration, invasion) following overexpression or knockdown .

What are the optimal conditions for producing functional recombinant human UPK1A?

For researchers seeking to produce recombinant UPK1A:

• Expression Systems:

  • E. coli: Suitable for producing fragments (e.g., His117~Gly232)

  • Mammalian cells (HEK293): Preferred for full-length protein with proper folding and post-translational modifications

• Tags and Purification:

  • Common tags: His, T7, Avi, or Fc

  • Purification typically employs Protein A/G chromatography

• Protein Characteristics:

  • Molecular weight: Approximately 29 kDa

  • Critical regions: The amino acid region 114-173 contains important epitopes

• Functional Verification:

  • Antibody recognition using specific antibodies like UPK1A/2924

  • Tetramerization assays to confirm proper oligomerization

How can researchers reconcile contradictory findings regarding UPK1A expression across different cancer types?

The seemingly contradictory roles of UPK1A across cancer types may be explained by:

• Tissue context-dependency: UPK1A may interact with tissue-specific partners

• Cancer stage-specific effects: Expression patterns may change during progression

• Methodological differences: Variability in detection methods, antibodies, and cutoff values

• Alternative splicing: Different isoforms may predominate in different tissues

• Post-translational modifications: Cell type-specific modifications may alter function

Research approach: Comparative multi-omics analysis across cancer types, careful validation of antibody specificity, and clear documentation of methodological parameters are essential to resolve these contradictions .

What is the potential of UPK1A as a biomarker in cancer diagnosis and prognosis?

UPK1A shows promise as a clinical biomarker with tissue-specific applications:

Immunohistochemical scoring system:

• Positive staining: ≥10% positive cancer cells

• High expression: ≥50% positive cancer cells

• Low expression: 10-50% positive cancer cells

How can UPK1A be targeted in experimental therapeutic approaches?

Emerging experimental approaches targeting UPK1A include:

• Modulating UPK1A expression:

  • Re-expressing UPK1A in gastric and esophageal cancers where it functions as a tumor suppressor

  • Inhibiting UPK1A in HCC where it appears to promote glycolysis and proliferation

• Targeting the HIF-1α/UPK1A feedback loop:

  • Disrupting HIF-1α binding to the UPK1A promoter to reduce expression in hypoxic tumors

  • Modulating downstream glycolytic pathways affected by this interaction

• UPK1A-AS1 modulation:

  • Tissue-specific approaches: promoting UPK1A-AS1 expression in ESCC; inhibiting it in PDAC and HCC

  • Targeting specific miRNA interactions (miR-1248, miR-138-5p)

These approaches require careful consideration of tissue context and should be validated in preclinical models before translation.